Back
ProQR Therapeutics NV 10K Form
Buy
51
PRQR
ProQR Therapeutics NV
Last Price:
3.64
Seasonality Move:
18.99%
7 Day Trial
ALL ACCESS PASS
$
7
Key Filings
10K form not available
Receive PRQR News And Ratings
See the #1 stock for the next 7 days that we like better than PRQR
PRQR Financial Statistics
Sales & Book Value
Annual Sales: | $7.05M |
---|---|
Cash Flow: | $-7.05M |
Price / Cash Flow: | 0 |
Annual Sales: | $0.34 |
Price / Book: | 13.7 |
Profitability
EPS (TTM): | -0.31540 |
---|---|
Net Income (TTM): | $-26.04M |
Gross Margin: | $0 |
Return on Equity: | -66.59% |
Return on Assets: | -19.08% |
ProQR Therapeutics NV Earnings Forecast
Key ProQR Therapeutics NV Financial Ratios
- The Selling, General & Administrative Expenses for PRQR have been equal to 249.25% of Gross Profit Margin.
- The Research & Development expenses have been 386.06% of Revenue.
- The Interest Expense is -4.28% of Operating Income.
- The Net Earning history of PRQR is -431.67% of Total Revenues.
- Per Share Earnings over the last 11 years have been positive in 5 years.
ProQR Therapeutics NV Stock Price Chart
Industry, Sector and Symbol
Stock Exchange: | NASDAQ |
---|---|
Industry: | Biotechnology |
Sector: | Health Care |
Current Symbol: | PRQR |
CUSIP: | N71542 |
Website: | proqr.com |
Debt
Debt-to-Equity Ratio: | 0.18 |
---|---|
Current Ratio: | 2.33 |
Quick Ratio: | 2.29 |
Price-to-Earnings
Trailing P/E Ratio: | 0 |
---|---|
Forward P/E Ratio: | 0 |
PRQR Technical Analysis vs Fundamental Analysis
Buy
51
ProQR Therapeutics NV (PRQR)
is a Buy
Is ProQR Therapeutics NV a Buy or a Sell?
-
ProQR Therapeutics NV stock is rated a Buy
The current ProQR Therapeutics NV [PRQR] share price is $3.61. The Score for PRQR is 51, which is 2% above its historic median score of 50, and infers lower risk than normal.